• Antimycin A4 for Reliable Cell Assays

  2026-09-02

  Learn how Antimycin A4 (SKU C8711) can clarify inconsistent viability and proliferation results by separating mitochondrial electron-transport effects from ATP-citrate lyase inhibition. This scenario-based guide covers assay design, handling, interpretation, and practical vendor-selection criteria for biomedical laboratories.

• Cefodizime in AMR Surveillance and Assay Design

  2026-09-02

  Cefodizime is a third-generation cephalosporin antibiotic whose value in microbiology research extends beyond broad-spectrum activity. This article explains how urban-rodent AMR surveillance can guide susceptibility assays, controls, and interpretation of Cefodizime data.

• 3X FLAG Peptide for Mechanistic Protein Assays

  2026-09-01

  Discover how the 3X (DYKDDDDK) Peptide can strengthen mechanistic protein assays, from interaction validation to metabolic signaling studies. This guide connects FLAG-tag design with the MAZ–BCKDK–G6PD research framework while addressing purification, detection, metal effects, and structural workflows.

• DiscoveryProbe Bioactive Compound Library Plus

  2026-09-01

  DiscoveryProbe Bioactive Compound Library Plus is a 5,072-compound research collection for pathway-focused screening, including apoptosis, protease, kinase, and signaling applications. Its pre-dissolved format and documented storage conditions support assay development, while thermal-shift results still require orthogonal binding validation.

• Ceftazidime: Mechanism, Evidence, and Research Use

  2026-08-31

  Ceftazidime is a third-generation cephalosporin with important activity against aerobic Gram-negative bacteria, including Pseudomonas aeruginosa. Its value in Gram-negative bacterial infection research depends on isolate-level susceptibility testing because β-lactamase production and mobile resistance genes can eliminate activity.

• ICG001: Reliable Wnt/β-Catenin Assays

  2026-08-31

  A practical, scenario-driven guide to using ICG001 (SKU A8217) in cell viability, proliferation, cytotoxicity, and Wnt pathway experiments. It connects mechanism, assay controls, preparation, interpretation, and product-selection criteria to improve experimental consistency.

• EdU Flow Cytometry Assay Kits (Cy5) Guide

  2026-08-30

  EdU Flow Cytometry Assay Kits (Cy5) detect DNA synthesis during the S phase by labeling newly replicated DNA and measuring Cy5 fluorescence by flow cytometry. They are suited to cell proliferation, genotoxicity, and pharmacodynamic studies, but should not be treated as a standalone measurement of viability, total cell number, or long-term growth.

• 5-Azacytidine Beyond Demethylation

  2026-08-29

  5-Azacytidine is more than a DNA demethylation agent: DNMT trapping can connect epigenetic reprogramming with ATR-mediated DNA damage and apoptosis. This translational perspective outlines how to design stronger mechanistic studies, combination experiments, and product workflows for leukemia and multiple myeloma research.

• UHRF1, Super-Enhancers, and Osteogenesis in SOP

  2026-08-28

  The reference study identifies a mechanistic connection between UHRF1-dependent DNA 5-methylcytosine, super-enhancer redistribution, TGM2 signaling, and autophagic flux in senile osteoporosis. By integrating methylome, chromatin, transcriptomic, cellular, and animal data, it links epigenetic remodeling to impaired mesenchymal stem cell osteogenesis and proposes the UHRF1–TGM2 axis as a potential intervention point.

• E-64d and the Translational Logic of Protease Control

  2026-08-28

  E-64d offers a cell-permeable, irreversible way to interrogate calpain and cysteine protease biology. This thought-leadership article connects its use in apoptosis, platelet signaling, neuroprotection, and cancer research with a recent plant study showing how regulated protein degradation can determine developmental outcomes.

• 28S rRNA Expansion Segments Build Nucleolar Layers

  2026-08-27

  Wei et al. show that 28S rRNA expansion segments act as multivalent architectural modules that can reconstitute layered nucleolar organization. Comparative, deletion, transfer, reconstitution, and simulation experiments connect ES length and interaction capacity with evolutionary differences between bipartite and tripartite nucleoli.

• Difloxacin HCl: Applied Research Workflows

  2026-08-27

  Difloxacin HCl supports two distinct research tracks: standardized antimicrobial susceptibility testing and exploratory multidrug resistance reversal in cell models. This guide connects practical stock preparation, assay design, checkpoint-aware controls, and troubleshooting without conflating bacterial growth inhibition with transporter-mediated sensitization.

• 28S rRNA Expansion Segments Build Nucleolar Layers

  2026-08-26

  Wei and colleagues show that 28S rRNA expansion segments act as multivalent architectural elements that help generate multilayered nucleolar organization. By combining cellular localization, in vitro reconstitution, comparative RNA analysis, segment deletion and transfer, and simulations, the study connects evolutionary RNA expansion with the emergence of more complex nucleolar architecture.

• NETs Activate cGAS-STING in Surgical Brain Injury

  2026-08-26

  This study identifies neutrophil extracellular traps (NETs) as an upstream driver of neuroinflammation, edema, neuronal injury, and neurological dysfunction after surgical brain injury. Its intervention and rescue experiments connect NET disruption to cGAS-STING signaling, while high-dose vitamin C emerges as a potential strategy for limiting NET formation.

• Stattic and STAT3: From Mechanism to Assay Design

  2026-08-25

  Stattic is a research-grade STAT3 inhibitor for dissecting phosphorylation, dimerization, nuclear signaling, apoptosis induction, and radiosensitization. This guide connects HNSCC assay design with mechanistic insights from a 2026 STING–STAT3–autophagy study while clearly separating validated evidence from translational hypotheses.

7979 records 1/532 page Next 12345 下5页 Last page